Mometasone Alternatives Compared
| Mometasone | Xolair (omalizumab) | Dupixent (dupilumab) |
|
|---|
| Mometasone | Xolair (omalizumab) | Dupixent (dupilumab) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Asthma - Maintenance. Mometasone may also be used for purposes not listed in this medication guide. |
Prescription only
Xolair is an injectable preparation that works by preventing IgE from binding to IgE receptors on mast cells and basophils and may be used to treat allergic asthma, nasal polyps, chronic idiopathic... View more |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, or prurigo nodularis. Injection site reactions and eye problems... View more |
Related suggestions Asthma, Maintenance
|
|||||||
| More about Mometasone | More about Xolair (omalizumab) | More about Dupixent (dupilumab) | ||||||||
| Ratings & Reviews | ||||||||||
|
Mometasone has an average rating of 6.3 out of 10 from a total of 31 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 32% reported a negative effect. |
Xolair has an average rating of 7.6 out of 10 from a total of 223 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 18% reported a negative effect. |
Dupixent has an average rating of 7.1 out of 10 from a total of 479 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Dupixent prices |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
|
|
||||||||
| Brand Names | ||||||||||
| Asmanex HFA, Asmanex Twisthaler |
N/A |
N/A |
||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
5 hours |
624 hours |
N/A |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 80 drugs are known to interact with Mometasone:
|
A total of 25 drugs are known to interact with Xolair:
|
A total of 89 drugs are known to interact with Dupixent:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
April 25, 2014 |
June 20, 2003 |
March 28, 2017 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
|||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.